GE Healthcare and Cellectis agree to sublicense for stem cell patents

CHALFONT ST. GILES, UK –– GE Healthcare Life Sciences, (NYSE: GE) and Cellectis Group (Alternext: ALCLS), the global genome engineering specialist, announced today that GE Healthcare has licenced Cellectis to develop, manufacture and sell models derived from stem cells for use in drug discovery and toxicity screening. The agreement follows the announcement that GE Healthcare [...]

FDA and Vivione Enter into a New Three-Year Cooperative Research and Development Agreement Aimed at Expanding the Capability of the RAPID-B™ Diagnostic System

LITTLE ROCK, AK - Vivione Biosciences Corporation (TSXV:VBI) today announced a new three-year Cooperative Research and Development Agreement (CRADA) with the Food and Drug Administration's (FDA) National Center for Toxicological Research (NCTR). The focus of the CRADA is to expand the capability of Vivione's RAPID-B™ diagnostic system. The Vivione RAPID-B™ system is a revolutionary high-performance [...]

ALPCO Releases STELLUX™ Chemiluminescence Human Total Proinsulin ELISA

Salem, NH -- ALPCO has announced the release of its Human Total Proinsulin Chemiluminescent ELISA, the newest assay to be launched in the company’s STELLUX™ product line. Similar to other STELLUX™ products available from ALPCO, the Human Total Proinsulin ELISA boasts a broad dynamic range (5-3,000 pg/mL) and superior sensitivity (0.455 pg/mL) that is ten [...]

90 MINUTE DNA RESULTS, A FIRST OF ITS KIND, COMING TO BENSALEM

LORTON, VA –– The Bensalem Township Police Department, in conjunction with Bode Technology, is launching a new initiative in the field of DNA testing. This pilot program known as “BodeHITS – Rapid DNA” will be the first of its kind in the country for law enforcement. Bensalem Township Police Department currently has its own local [...]

Irvine Scientific Introduces New Cell Therapy Products for Cell Expansion and Differentiation

SANTA ANA, California -- Irvine Scientific, a strategic manufacturer of cell culture media, announced today the expansion of their cell therapy product portfolio with the launch of new media and recombinant growth factors. The product line is designed to provide an integrated workflow solution for the culture of human stem cells and primary cells. In [...]

Dynasil’s RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy

WATERTOWN, Mass. -- Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received four grants totaling $4.0 million under the U.S. Department of Energy's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. "RMD's world-class research in nuclear detection continues to be on the cutting [...]

PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma

PISCATAWAY, N.J. -- PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the Singulex® Erenna® Immunoassay technology. Based on an innovative single-molecule counting (SMC) technology, these services are designed to provide sub-picogram per ml sensitivity for analytes in human serum or plasma. The background reduction [...]

Microtrac obtains US Food and Drug Administration (FDA) Establishment Registration for Particle Analysis Services

Microtrac, the global pioneer of instrumentation and services for particle characterization, is pleased to announce that their Particle Analysis Laboratory (PAL), located in Largo, Florida is registered with the US Food and Drug Administration under the “FDA Drug Establishment Registration” program. With the PAL having acquired FDA registration, Microtrac will accept pharmaceutical ingredients, including those [...]

Leading EU and UK Pesticide Testing Labs Collaborate with Thermo Fisher Scientific

RUNCORN, UK – In efforts to ensure safe and healthy food, two leading European food testing laboratories are collaborating with Thermo Fisher Scientific at the company’s new Pesticide Analysis Center of Excellence to improve methods for detecting and measuring pesticide residues in food. The European Union Reference Laboratories (EURL) for Residues of Pesticides in Fruits [...]

Transgenomic Appoints Stephen R. Miller as Senior Vice President and General Manager of Patient Testing Business Unit

OMAHA, Neb. -- Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Stephen R. Miller has been named Senior Vice President and General Manager, Patient Testing. Mr. Miller brings over 22 years of experience [...]

Access IBO on Knowledge Center